Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

55.27
BATS BZX Real-Time Price
As of 1:34pm ET
 -0.04 / -0.07%
Today’s Change
45.69
Today|||52-Week Range
60.07
+4.64%
Year-to-Date
Gilead Sciences Bucks Tradition, Takes 'Low Road' on New Hepatitis C Drug Price
11:40am / TheStreet.com - Paid Partner Content
Can Gilead Sciences Rebound in the Second Half of 2016?
Jun 25 / MotleyFool.com - Paid Partner Content
Regulus Therapeutics Inc. Clinical Hold: Should Investors Be Yellow-Bellied?
Jun 27 / MotleyFool.com - Paid Partner Content
Why Investors Are Paying a Premium for These 3 Drugmakers
Jun 24 / MotleyFool.com - Paid Partner Content
Better Buy: Merck & Co. Inc. vs. AbbVie
Jun 27 / MotleyFool.com - Paid Partner Content
Sanofi's Likely Sweetener for Medivation Panned
Jun 23 / TheStreet.com - Paid Partner Content
Why Agenus' Stock Has Stumbled in 2016
Jun 27 / MotleyFool.com - Paid Partner Content
Incyte Reports Epacadostat Combination Study Initiation
Jun 23 / Zacks.com - Paid Partner Content
The 5 Best Healthcare ETFs
Jun 26 / MotleyFool.com - Paid Partner Content
Zika vaccine maker's stock is on fire
Jun 22 / CNNMoney.com

Today’s Trading

Previous close55.31
Today’s open55.94
Day’s range55.12 - 55.94
Volume715,302
Average volume (3 months)9,001,867
Market cap$153.1B
Dividend yield3.33%
Data as of 1:34pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)-61.67%
Earnings growth (this year)+3.59%
Earnings growth (next 5 years)+4.30%
Revenue growth (last year)-7.92%
P/E ratio33.9
Price/Sales3.87
Price/Book3.44

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc+17.50+2.19%
NVSNovartis+1.89+2.45%
BMYBristol-Myers Squibb+1.13+1.61%
SNYSanofi+1.17+2.99%
Data as of 1:34pm ET, 06/28/2016

Financials

Next reporting dateJuly 29, 2016
EPS forecast (this quarter)$0.91
Annual revenue (last year)$38.8B
Annual profit (last year)$4.4B
Net profit margin11.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts

Partner Offers

Search for Jobs